Abstract | OBJECTIVE: To measure the levels of Tumor necrosis factor (TNF)-like ligand 1A (TL1A) and decoy receptor 3 (DcR3) in serum and synovial fluid (SF) of patients with rheumatoid arthritis (RA). To evaluate the effect of recombinant human (rh) TL1A on interleukin (IL)-17 production and IL-17mRNA expression. METHODS: The serum and SF levels of TL1A and DcR3, and the production of IL-17 by rhTL1A-treated PBMC were measured by enzyme-linked immunosorbent assay (ELISA). The expression of IL-17 mRNA by rhTL1A-treated PBMC was measured by real-time reverse transcriptase polymerase chain reaction (RT-PCR). We also tested the change of TL1A and DcR3 level following TNF-α blockade therapy. RESULTS: Serum TL1A and DcR3 levels were higher in RA patients. This increase was more significant in RF and anti-CCP positive patients. TL1A and DcR3 levels were higher in SF samples than in paired sera. TL1A and DcR3 decreased after anti-TNF treatment. rhTL1A increased the production of IL-17 protein and the expression of IL-17mRNA. CONCLUSION: TL1A and DcR3 may be of pathogenic and potentially of therapeutic importance in RA patients.
|
Authors | Zijuan Xiu, Hui Shen, Ye Tian, Liping Xia, Jing Lu |
Journal | Cytokine
(Cytokine)
Vol. 72
Issue 2
Pg. 185-9
(Apr 2015)
ISSN: 1096-0023 [Electronic] England |
PMID | 25647275
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Interleukin-17
- Receptors, Tumor Necrosis Factor, Member 6b
- TNFRSF6B protein, human
- Tumor Necrosis Factor Ligand Superfamily Member 15
- Tumor Necrosis Factor-alpha
- Infliximab
|
Topics |
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal
- Arthritis, Rheumatoid
(immunology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Infliximab
(administration & dosage, therapeutic use)
- Interleukin-17
(genetics, immunology)
- Leukocytes, Mononuclear
(immunology, metabolism)
- Male
- Middle Aged
- Real-Time Polymerase Chain Reaction
- Receptors, Tumor Necrosis Factor, Member 6b
(blood, metabolism)
- Synovial Fluid
(immunology)
- Tumor Necrosis Factor Ligand Superfamily Member 15
(blood, metabolism)
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|